Fig. 1
From: CRIP1 inhibits cutaneous melanoma progression through TFAM-mediated mitochondrial biogenesis
Association between CRIP1 expression and clinical features. (A) CRIP1 mRNA in cutaneous melanoma was significantly lower than that in normal tissue. (B) CRIP1 expression in melanoma from the HPA database. (C) The most significant difference in CRIP1 expression was from T1-2 to T4 stage tissues. (D) In the TCGA database, there was no significant difference between CRIP1 expression and N-stage of melanoma tissues. (E) CRIP1 mRNA was lower in melanomas with ulcers than in melanomas without ulcers. (F) CRIP1 expression progressively decreased from Clark grades I-III to grade IV and V melanomas.
